# Hyperbaric Oxygen Therapy for Peripheral Neuropathy Due to Paclitaxel Analogs

> **NCT06819501** · NA · NOT_YET_RECRUITING · sponsor: **Guangdong Provincial People's Hospital** · enrollment: 226 (estimated)

## Conditions studied

- Breast Cancers

## Interventions

- **DEVICE:** hyperbaric oxygenation treatment
- **BEHAVIORAL:** routine care

## Key facts

- **NCT ID:** NCT06819501
- **Lead sponsor:** Guangdong Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-02-05
- **Primary completion:** 2026-09-01
- **Final completion:** 2026-09-01
- **Target enrollment:** 226 (ESTIMATED)
- **Last updated:** 2025-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06819501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06819501, "Hyperbaric Oxygen Therapy for Peripheral Neuropathy Due to Paclitaxel Analogs". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06819501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
